Pages that link to "Q40334778"

The following pages link to Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry (Q40334778):

Displaying 39 items.

• New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale. (Q30856181) (← links)
• Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin (Q33798554) (← links)
• 'Old' antibiotics for emerging multidrug-resistant bacteria (Q34565772) (← links)
• Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients. (Q34597749) (← links)
• Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine (Q35598359) (← links)
• High performance liquid chromatography-mass spectrometry assay for polymyxin B1 and B2 in human plasma (Q36089663) (← links)
• Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? (Q36335694) (← links)
• Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis. (Q36644676) (← links)
• Population pharmacokinetic analysis of colistin in burn patients. (Q36785854) (← links)
• Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models. (Q37120088) (← links)
• Development and validation of a liquid chromatography-mass spectrometry assay for polymyxin B in bacterial growth media. (Q37669021) (← links)
• Pharmacokinetic evaluation of colistin sodium (Q37815508) (← links)
• Colistin: an update on the antibiotic of the 21st century (Q38048852) (← links)
• Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant Gram-negative bacteria. (Q38193538) (← links)
• Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. (Q38677017) (← links)
• Lipopeptides as therapeutics: applications and in vivo quantitative analysis (Q39037677) (← links)
• Clinical Pharmacokinetics and Pharmacodynamics of Colistin. (Q39333751) (← links)
• Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats. (Q39693073) (← links)
• Pharmacokinetics of Colistin and Colistimethate Sodium After a Single 80-mg Intravenous Dose of CMS in Young Healthy Volunteers (Q39753735) (← links)
• Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. (Q40821276) (← links)
• Influence of the Molecular Weight and Charge of Antibiotics on Their Release Kinetics From Gelatin Nanospheres (Q41430876) (← links)
• Determination of selected veterinary antimicrobials in poultry excreta by UHPLC-MS/MS, for application in Salmonella control programs. (Q41514915) (← links)
• Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses (Q43052340) (← links)
• Colistin distribution in the peritoneal fluid of a patient with severe peritonitis. (Q43219296) (← links)
• LC-MS/MS determination of colistin in Mueller-Hinton broth for in vitro pharmacodynamic studies. (Q45281920) (← links)
• Feasibility of microdialysis for determination of protein binding and target site pharmacokinetics of colistin in vivo (Q46237714) (← links)
• Reply to Magréault et al. (Q50049251) (← links)
• Dose suggestions for intravenous colistin in pediatric patients: Caution required (Q50049561) (← links)
• Impact of colistin sulfate treatment of broilers on the presence of resistant bacteria and resistance genes in stored or composted manure (Q51625689) (← links)
• A Population WB-PBPK Model of Colistin and its Prodrug CMS in Pigs: Focus on the Renal Distribution and Excretion. (Q52358038) (← links)
• Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys. (Q53217740) (← links)
• Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae. (Q55347292) (← links)
• Multidrug resistant Acinetobacter baumannii ventriculostomy-related infection, treated by a Colistin, Tigecycline and intraventricular fibrinolysis (Q57481258) (← links)
• Rapid, simple, and clinically applicable high-performance liquid chromatography method for clinical determination of plasma colistin concentrations (Q58765783) (← links)
• An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection (Q92178245) (← links)
• Bioanalysis and Stability of Polymyxins (Q92302860) (← links)
• Pharmacokinetics of Polymyxins in Animals (Q92302864) (← links)
• Quantitative determination of colistin A/B and colistin methanesulfonate in biological samples using hydrophilic interaction chromatography tandem mass spectrometry (Q93234701) (← links)
• Quantification of Colistin in Plasma by Liquid Chromatography-Tandem Mass Spectrometry: Application to a Pharmacokinetic Study (Q95328513) (← links)